Search

Search Constraints

You searched for: Author/Creator Castellano, Aurora

Search Results

1. Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group. Issue 10 (29th April 2015)

2. Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients. Issue 5 (3rd December 2019)

3. Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants. Issue 4 (1st April 2021)

4. MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma. (3rd June 2017)

5. Neuroblastoma with symptomatic epidural compression in the infant: The AIEOP experience. Issue 8 (12th March 2014)

6. Neuroblastoma-secreted exosomes carrying miR‐375 promote osteogenic differentiation of bone-marrow mesenchymal stromal cells. Issue 1 (1st January 2020)

7. Neuroblastoma‐secreted exosomes carrying miR‐375 promote osteogenic differentiation of bone‐marrow mesenchymal stromal cells. Issue 1 (3rd June 2020)

8. PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance. (2nd January 2016)

9. Radiogenomics prediction for MYCN amplification in neuroblastoma: A hypothesis generating study. Issue 9 (18th May 2021)

10. Tandem high-dose 131I-MIBG therapy supported by dosimetry in pediatric patients with relapsed-refractory high-risk neuroblastoma: the Bambino Gesu' Children's Hospital experience. Issue 2 (February 2022)